We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kimberly-Clark Corporation (KMB - Free Report) is one of the leading players in several consumer product categories including diapers, paper goods, and female personal care. Kimberly-Clark regularly focuses on improving its products through innovation in order to remain competitive and drive growth. Kimberly-Clark’s cost saving measures and strong international presence will drive growth in the long-term. However, Kimberly-Clark has been facing headwinds of late, which is driving down its share price. Sluggish organic sales growth, unfavorable currency and increased competition are eroding sales growth. Due to this, investors are eagerly awaiting Kimberly-Clark’s earnings report.
Investors should also note the recent earnings estimate revisions for KMB, as the consensus estimate has slightly increased over the past 30 days period. KMB has a mixed history in earnings season. KMB has delivered three positive and one negative surprise in the last four quarters, making for a positive average surprise of 1.38%.
Currently, KMB has a Zacks Rank #3 (Hold). You can seethe complete list of today’s Zacks #1 Rank stocks here. The Zacks Rank could definitely change following Kimberly-Clark’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: KMB lags on earnings. Our consensus called for EPS of $1.54, and the company posted adjusted EPS of $1.57 per share instead. Investors should note that these figures take out stock option expenses.
Revenue: KMB posted revenues of $4.483 billion, missing our consensus estimate of $4.507 billion.
Key Stats to Note: Organic sales declined 1% in the quarter, due to a decline in North America. However, organic sales growth increased in developing and emerging markets.
Stock Price: Shares were inactive in pre-market trading.
Check back later for our full write up on this KMB earnings report later!
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Kimberly-Clark (KMB) Beats Q1 Earnings; Lags Revenue
Kimberly-Clark Corporation (KMB - Free Report) is one of the leading players in several consumer product categories including diapers, paper goods, and female personal care. Kimberly-Clark regularly focuses on improving its products through innovation in order to remain competitive and drive growth. Kimberly-Clark’s cost saving measures and strong international presence will drive growth in the long-term. However, Kimberly-Clark has been facing headwinds of late, which is driving down its share price. Sluggish organic sales growth, unfavorable currency and increased competition are eroding sales growth. Due to this, investors are eagerly awaiting Kimberly-Clark’s earnings report.
Investors should also note the recent earnings estimate revisions for KMB, as the consensus estimate has slightly increased over the past 30 days period. KMB has a mixed history in earnings season. KMB has delivered three positive and one negative surprise in the last four quarters, making for a positive average surprise of 1.38%.
Currently, KMB has a Zacks Rank #3 (Hold). You can seethe complete list of today’s Zacks #1 Rank stocks here. The Zacks Rank could definitely change following Kimberly-Clark’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: KMB lags on earnings. Our consensus called for EPS of $1.54, and the company posted adjusted EPS of $1.57 per share instead. Investors should note that these figures take out stock option expenses.
Revenue: KMB posted revenues of $4.483 billion, missing our consensus estimate of $4.507 billion.
Key Stats to Note: Organic sales declined 1% in the quarter, due to a decline in North America. However, organic sales growth increased in developing and emerging markets.
Stock Price: Shares were inactive in pre-market trading.
Check back later for our full write up on this KMB earnings report later!
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>